COMMUNIQUÉS West-GlobeNewswire
-
BetterLife Announces Intent to Complete Private Placement of Units
04/05/2024 - 00:00 -
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:00 -
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:00 -
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:01 -
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:01 -
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:01 -
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
03/05/2024 - 22:05 -
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:05 -
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
03/05/2024 - 22:05 -
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
03/05/2024 - 22:05 -
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to June 3, 2024
03/05/2024 - 22:30 -
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
03/05/2024 - 22:30 -
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:30 -
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:30 -
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:30 -
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:30 -
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2024 - 22:45 -
Compass Pathways to announce first quarter financial results on May 8, 2024
03/05/2024 - 22:58 -
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process
03/05/2024 - 17:30
Pages